Two Sigma Securities’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Two Sigma Securities’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,641	Closed	-$362K	–	3235
2018 Q2	$362K	Buy	+3,641	New	+$315K	﹤0.01%	1947
2015 Q3	–	Sell	-2,041	Closed	-$235K	–	307
2015 Q2	$235K	Buy	+2,041	New	+$214K	0.39%	69

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Securities's CBPO Position: Q3 2018 in Review

Two Sigma Securities sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 3,641 shares — an estimated $362K sold.

Two Sigma Securities first reported a position in CBPO in Q2 2015 and held it in 2 quarters. The position peaked at $362K in Q2 2018. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Two Sigma Securities reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Two Sigma Securities sold 3,641 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $362K.
Two Sigma Securities first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 2 quarters.
Two Sigma Securities's China Biologic Products Holdings, Inc. position peaked at $362K in Q2 2018.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Two Sigma Securities's 13F filing for Q3 2018, filed 14 Nov 2018.